Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to $4.1 million.

  • KORU Medical Systems' Cost of Revenue rose 3819.68% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year increase of 2377.15%. This contributed to the annual value of $12.3 million for FY2024, which is 427.81% up from last year.
  • As of Q3 2025, KORU Medical Systems' Cost of Revenue stood at $4.1 million, which was up 3819.68% from $3.7 million recorded in Q2 2025.
  • KORU Medical Systems' Cost of Revenue's 5-year high stood at $4.1 million during Q3 2025, with a 5-year trough of $2.2 million in Q1 2021.
  • In the last 5 years, KORU Medical Systems' Cost of Revenue had a median value of $3.0 million in 2023 and averaged $3.0 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first skyrocketed by 5106.8% in 2021, then crashed by 2260.05% in 2023.
  • Over the past 5 years, KORU Medical Systems' Cost of Revenue (Quarter) stood at $2.7 million in 2021, then increased by 22.86% to $3.3 million in 2022, then decreased by 12.6% to $2.9 million in 2023, then increased by 14.74% to $3.3 million in 2024, then increased by 26.31% to $4.1 million in 2025.
  • Its Cost of Revenue stands at $4.1 million for Q3 2025, versus $3.7 million for Q2 2025 and $3.6 million for Q1 2025.